BioVie
BIVI
37 hedge funds and large institutions have $2.86M invested in BioVie in 2026 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 10 reducing their positions, and 3 closing their positions.
171% more capital inflows, than outflows
Capital inflows: $1.11M | Capital outflows: $409K
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
5.85% more ownership
Funds ownership: 13.67% → 19.52% (+5.9%)
6% more funds holding
Funds holding: 35 → 37 (+2)
10% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$833K |
| 2 |
Renaissance Technologies
New York
|
+$94.2K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$79.6K |
| 4 |
Persistent Asset Partners
Hong Kong
|
+$23.6K |
| 5 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
+$21.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Diametric Capital
Boston,
Massachusetts
|
-$178K |
| 2 |
Prelude Capital Management
New York
|
-$93.4K |
| 3 |
Philadelphia Trust Company
Philadelphia,
Pennsylvania
|
-$39.3K |
| 4 |
HRT Financial
New York
|
-$32K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$21.1K |
BIVI Hedge Fund Activity: Q2 2026 in Review
37 of the 8,401 institutional investors tracked by Wall St. Rank reported a position in BioVie (BIVI) for Q2 2026, worth a combined $2.86M — up 98% from $1.44M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new BIVI positions and 3 closed out — a net gain of 2 holders — while 9 added to existing stakes and 10 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $833K. The largest seller was Diametric Capital, cutting an estimated $178K.
- 37 institutional investors held BioVie (BIVI) as of Q2 2026, up from 35 in Q1 2026.
- Funds reported $2.86M of BioVie stock for Q2 2026, up 98% quarter-over-quarter.
- 5 funds opened new BioVie positions in Q2 2026 and 3 closed out, a net change of +2 holders.
- The largest BioVie buyer in Q2 2026 was Morgan Stanley, an estimated $833K added.
- The largest BioVie seller in Q2 2026 was Diametric Capital, an estimated $178K sold.
Based on aggregated 13F filings for Q2 2026.